secwatch / observer
8-K/A filed September 22, 2021, 7:59 PM ET ticker CRBP CIK 0001595097
leadership confidence high sentiment neutral materiality 0.60

Corbus discloses CMO separation terms: $454K severance, option extension to June 2023

Corbus Pharmaceuticals Holdings, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Barbara White

Chief Medical Officer
CRBP · Corbus Pharmaceuticals Holdings, Inc.
Effective
2021-09-17
Filed
September 22, 2021, 7:59 PM ET
On September 17, 2021, Dr. White and the Company entered into a Separation and General Release Agreement (the “Separation Agreement”) related to Dr. White’s resignation as Chief Medical Officer from the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Barbara White resigned as Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc..

Action
resigned
Role
Chief Medical Officer
Exact text from the filing
On September 17, 2021, Dr. White and the Company entered into a Separation and General Release Agreement (the “Separation Agreement”) related to Dr. White’s resignation as Chief Medical Officer from the Company.
View on SEC.gov

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-21-023317
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.